SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-16-128640
Filing Date
2016-06-21
Accepted
2016-06-21 17:25:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 425 a16-13380_4425.htm 425 23655
2 GRAPHIC g133804bii001.gif GRAPHIC 9715
3 GRAPHIC g133804bii002.gif GRAPHIC 5099
4 GRAPHIC g133804bii003.gif GRAPHIC 6992
  Complete submission text file 0001104659-16-128640.txt   55911
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filed by) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34921 | Film No.: 161725096
SIC: 2834 Pharmaceutical Preparations